AI
| Followers | 843 |
| Posts | 122985 |
| Boards Moderated | 9 |
| Alias Born | 09/05/2002 |
Friday, February 25, 2011 4:19:15 PM
FoB Cheat Sheet
This chart shows why the hullabaloo over the 12-year exclusivity
period for US biologics is much ado about nothing (#msg-59912094).
For every big-selling biologic, US patent protection continues longer
than the statutory exclusivity period.
(The 12-year exclusivity could become consequential if the
US patents on these drugs were found to be unenforceable,
but there’s no indication that such an outcome is likely.)
Source: http://www.pharma-mag.com/Portals/0/Whitepapers/newport-biologics.pdf
This chart shows why the hullabaloo over the 12-year exclusivity
period for US biologics is much ado about nothing (#msg-59912094).
For every big-selling biologic, US patent protection continues longer
than the statutory exclusivity period.
(The 12-year exclusivity could become consequential if the
US patents on these drugs were found to be unenforceable,
but there’s no indication that such an outcome is likely.)
Source: http://www.pharma-mag.com/Portals/0/Whitepapers/newport-biologics.pdf
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
